Axogen completes acquisition of BioCircuit; expects ~$6M Q4-2026 and ~$34M 2027 revenue
Axogen announced completion of its acquisition of BioCircuit Technologies and the addition of FDA-cleared NerveTape.Key Highlights:Original SEC Filing: Axogen, Inc. [ AXGN ] - 8-K - Oct. 01, 2026This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information wit…